Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Clinical & Experimental Ophthalmology
|
July 16, 2025
Inhibitory Effects of 3',4'-Dihydroxyflavonol in a Rabbit Model of Minimally Invasive Bleb Surgery With PreserFlo MicroShunt
Zoe Pasvanis, Roy C K Kong, Elsa C Chan, et al.
Scientific Reports
|
January 18, 2022
Transcriptomic analysis of choroidal neovascularization reveals dysregulation of immune and fibrosis pathways that are attenuated by a novel anti-fibrotic treatment
Alice Brandli, Fay L Khong, Roy C K Kong, et al.
International Journal of Molecular Sciences
|
October 16, 2024
3',4'-Dihydroxyflavonol Inhibits Fibrotic Response in a Rabbit Model of Glaucoma Filtration Surgery
Zoe Pasvanis, Roy C K Kong, Manisha H Shah, et al.
Molecular and Cellular Endocrinology
|
February 9, 2010
Membrane receptors: structure and function of the relaxin family peptide receptors
Roy C K Kong, Patrick J Shilling, Derek K Lobb, et al.
Biochemistry
|
July 2, 2014
Mapping key regions of the RXFP2 low-density lipoprotein class-A module that are involved in signal activation
Roy C K Kong, Ross A D Bathgate, Shoni Bruell, et al.
Translational Vision Science & Technology
|
August 18, 2022
Inhibitory Effects of 3',4'-Dihydroxyflavonol in a Mouse Model of Glaucoma Filtration Surgery and TGFβ1-Induced Responses in Human Tenon's Fibroblasts
Jennifer C Fan Gaskin, Roy C K Kong, Manisha H Shah, et al.
The Journal of Biological Chemistry
|
August 9, 2013
The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation
Roy C K Kong, Emma J Petrie, Biswaranjan Mohanty, et al.
Frontiers in Endocrinology
|
November 26, 2013
Chimeric RXFP1 and RXFP2 Receptors Highlight the Similar Mechanism of Activation Utilizing Their N-Terminal Low-Density Lipoprotein Class A Modules
Shoni Bruell, Roy C K Kong, Emma J Petrie, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Clinical & Experimental Ophthalmology
|
July 16, 2025
Inhibitory Effects of 3',4'-Dihydroxyflavonol in a Rabbit Model of Minimally Invasive Bleb Surgery With PreserFlo MicroShunt
Zoe Pasvanis, Roy C K Kong, Elsa C Chan, et al.
Scientific Reports
|
January 18, 2022
Transcriptomic analysis of choroidal neovascularization reveals dysregulation of immune and fibrosis pathways that are attenuated by a novel anti-fibrotic treatment
Alice Brandli, Fay L Khong, Roy C K Kong, et al.
International Journal of Molecular Sciences
|
October 16, 2024
3',4'-Dihydroxyflavonol Inhibits Fibrotic Response in a Rabbit Model of Glaucoma Filtration Surgery
Zoe Pasvanis, Roy C K Kong, Manisha H Shah, et al.
Molecular and Cellular Endocrinology
|
February 9, 2010
Membrane receptors: structure and function of the relaxin family peptide receptors
Roy C K Kong, Patrick J Shilling, Derek K Lobb, et al.
Biochemistry
|
July 2, 2014
Mapping key regions of the RXFP2 low-density lipoprotein class-A module that are involved in signal activation
Roy C K Kong, Ross A D Bathgate, Shoni Bruell, et al.
Translational Vision Science & Technology
|
August 18, 2022
Inhibitory Effects of 3',4'-Dihydroxyflavonol in a Mouse Model of Glaucoma Filtration Surgery and TGFβ1-Induced Responses in Human Tenon's Fibroblasts
Jennifer C Fan Gaskin, Roy C K Kong, Manisha H Shah, et al.
The Journal of Biological Chemistry
|
August 9, 2013
The relaxin receptor (RXFP1) utilizes hydrophobic moieties on a signaling surface of its N-terminal low density lipoprotein class A module to mediate receptor activation
Roy C K Kong, Emma J Petrie, Biswaranjan Mohanty, et al.
Frontiers in Endocrinology
|
November 26, 2013
Chimeric RXFP1 and RXFP2 Receptors Highlight the Similar Mechanism of Activation Utilizing Their N-Terminal Low-Density Lipoprotein Class A Modules
Shoni Bruell, Roy C K Kong, Emma J Petrie, et al.
Page
of 1